Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018
Tuesday, April 24, 2018 5:15 p.m.: Panel Discussion - Non-Invasive Biomarkers - How Near Are We? Wednesday, April 25, 2018 3:30 p.m.: Keynote – Clinical Trials & Endpoints in NASH Cirrhosis
The NASH Summit is the industry’s most comprehensive conference on drug development for non-alcoholic steatohepatitis (NASH) focused on drug discovery through late stage clinical development. It brings together thought leaders from across the industry to give detailed presentations across multiple streams of learning in the NASH sector.
Positive Results in NASH Cirrhosis
Source: Galectin Therapeutics Inc.